Found 16 matching trials
PK and Bioavailability Comparison of Tofacitinib Between a Modified Release and The Immediate Release Formulation PHASE1 A study to characterize the single-dose and steady-state pharmacokinetics o...
Show More Location
Shuguang Hospital Affiliated to Shanghai University of TCM/Phase I Unit
Learn More & Join Trial
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate PHASE3 This study \[contRAst 1 (201790: NCT03980483)\] is a phase 3, randomized, m...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis PHASE2 This study has been designed to explore the clinical efficacy and safety of...
Show More Location
Huashan Hospital affiliated to Fudan University
Learn More & Join Trial
A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis PHASE3 This is a comparative study of CP 690,550, Humira (adalimumab) and placebo ...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers PHASE1 This study is an open-label, randomized, fasted, single dose, crossover stu...
Show More Learn More & Join Trial
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) PHASE3 This study \[contRAst 2 (201791: NCT03970837)\] is a phase 3, randomized, m...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis PHASE1 This is a pilot study to determine whether further research is warranted to...
Show More Location
Oregon Health & Science University
Learn More & Join Trial
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease PHASE2 The study hypothesis is to establish the safety and tolerability of long-te...
Show More Location
Alliance Clinical Research
Learn More & Join Trial
Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc) PHASE1 This Phase I/II placebo controlled trial will evaluate tofacitinib in subje...
Show More Location
University of Michigan
Learn More & Join Trial
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease PHASE2 This study investigates safety and efficacy of CP-690,550 in adult patients...
Show More Location
ACRI - Phase 1, LLC
Learn More & Join Trial